Digital Health (Nov 2022)

Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study

  • Tanvi Lakhtakia,
  • Ameya Bondre,
  • Prabhat Kumar Chand,
  • Nirmal Chaturvedi,
  • Soumya Choudhary,
  • Danielle Currey,
  • Siddharth Dutt,
  • Azaz Khan,
  • Mohit Kumar,
  • Snehil Gupta,
  • Srilakshmi Nagendra,
  • Preethi V Reddy,
  • Abhijit Rozatkar,
  • Luke Scheuer,
  • Yogendra Sen,
  • Ritu Shrivastava,
  • Rahul Singh,
  • Jagadisha Thirthalli,
  • Deepak Kumar Tugnawat,
  • Anant Bhan,
  • John A Naslund,
  • Vikram Patel,
  • Matcheri Keshavan,
  • Urvakhsh Meherwan Mehta,
  • John Torous

DOI
https://doi.org/10.1177/20552076221133758
Journal volume & issue
Vol. 8

Abstract

Read online

Objective To examine feasibility and acceptability of smartphone mental health app use for symptom, cognitive, and digital phenotyping monitoring among people with schizophrenia in India and the United States. Methods Participants in Boston, USA and Bhopal and Bangalore, India used a smartphone app to monitor symptoms, play cognitive games, access relaxation and psychoeducation resources and for one month, with an initial clinical and cognitive assessment and a one-month follow-up clinical assessment. Engagement with the app was compared between study sites, by clinical symptom severity and by cognitive functioning. Digital phenotyping data collection was also compared between three sites. Results By Kruskal-Wallis rank-sum test, we found no difference between app activities completed or digital phenotyping data collected across the three study sites. App use also did not correlate to clinical or cognitive assessment scores. When using the app for symptom monitoring, preliminary findings suggest app-based assessment correlate with standard cognitive and clinical assessments. Conclusions Smartphone app for symptom monitoring and digital phenotyping for individuals with schizophrenia appears feasible and acceptable in a global context. Clinical utility of this app for real-time assessments is promising, but further research is necessary to determine the long-term efficacy and generalizability for serious mental illness.